Number of items: 4.
2021
Xu, Hongwei,
Chen, Kefei,
Shang, Runze,
Chen, Xinyan,
Zhang, Yi,
Song, Xinhua,
Evert, Matthias,
Zhong, Sheng,
Li, Bo,
Calvisi, Diego F. and
Chen, Xin
(2021)
Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma.
Cell Death & Disease 12 (10).
Fulltext not available.
2020
Chen, Xinyan,
Kiss, Andras,
Schaff, Zsuzsa,
Evert, Katja,
Zhang, Yi,
Zhong, Sheng,
Wang, Jingxiao,
Evert, Matthias,
Calvisi, Diego F. and
Chen, Xin
(2020)
CDK9 is dispensable for YAP‐driven hepatoblastoma development.
Pediatric Blood & Cancer 67 (5).
Fulltext not available.
Shang, Runze,
Song, Xinhua,
Wang, Pan,
Zhou, Yi,
Lu, Xinjun,
Wang, Jingxiao,
Xu, Meng,
Chen, Xinyan,
Utpatel, Kirsten,
Che, Li,
Liang, Binyong,
Cigliano, Antonio,
Evert, Matthias,
Calvisi, Diego F. and
Chen, Xin
(2020)
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma.
Gut 70 (9), pp. 1746-1757.
Fulltext not available.
2019
Wang, Jingxiao ,
Wang, Haichuan ,
Peters, Michele,
Ding, Ning,
Ribback, Silvia,
Utpatel, Kirsten,
Cigliano, Antonio,
Dombrowski, Frank,
Xu, Meng,
Chen, Xinyan,
Song, Xinhua,
Che, Li,
Evert, Matthias,
Cossu, Antonio,
Gordan, John,
Zeng, Yong,
Chen, Xin and
Calvisi, Diego F.
(2019)
Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
Journal of Hepatology 71 (4), pp. 742-752.
Fulltext not available.
This list was generated on Mon Dec 9 10:17:52 2024 CET.